June 11th, 1:00pm ET
Significant cases decided in 2024 and 2025 are shaping the landscape of enforcement for clinical laboratories. Government regulators continue to focus on medical necessity and improper business relationships, but they have expanded their focus to other issues that may present risks to labs. From laws on marketing relationships to the design of requisition forms, what lessons can labs learn to avoid future compliance risks?
This presentation will provide:
- An overview of recent lab enforcement trends, including cases related to the False Claims Act and Anti-Kickback Statute
- How the Trump Administration is impacting the FCA landscape and what to expect from this administration
- Compliance and targeted risk management strategies
Speakers
Danielle Tangorre
Partner, Robinson+Cole
Seth Orkand
Partner, Robinson+Cole